Rare cutaneous toxicity of immune checkpoint inhibitors: A case of durvalumab-induced dermatomyositis - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue European Journal of Cancer Année : 2021

Dates et versions

hal-03311531 , version 1 (02-08-2021)

Identifiants

Citer

Cyrille Coustal, Aurélie Du Thanh, François Roubille, Eric Assenat, Alexandre T.J. Maria. Rare cutaneous toxicity of immune checkpoint inhibitors: A case of durvalumab-induced dermatomyositis. European Journal of Cancer, 2021, 155, pp.25-27. ⟨10.1016/j.ejca.2021.06.031⟩. ⟨hal-03311531⟩
61 Consultations
97 Téléchargements

Altmetric

Partager

Gmail Mastodon Facebook X LinkedIn More